Analysis of Reportable Segments
Medtronic PLC operates in 4 segments: Cardiovascular Portfolio; Neuroscience Portfolio; Medical Surgical Portfolio; and Diabetes Operating Unit.
Segment Profit Margin
Medtronic PLC, profit margin by reportable segment
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Cardiovascular Portfolio | 37.82% | 38.32% | 39.50% | 35.74% | 35.53% | 39.39% |
| Neuroscience Portfolio | 41.89% | 40.37% | 42.86% | 38.58% | 37.73% | 40.56% |
| Medical Surgical Portfolio | 37.66% | 33.87% | 39.08% | 34.58% | 36.45% | 38.48% |
| Diabetes Operating Unit | 15.84% | 16.71% | 24.94% | 24.78% | 23.06% | 30.91% |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment profit margin | Cardiovascular Portfolio | Cardiovascular Portfolio segment profit margin ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
| Neuroscience Portfolio | Neuroscience Portfolio segment profit margin ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 not reaching 2022 level. | |
| Medical Surgical Portfolio | Medical Surgical Portfolio segment profit margin ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 not reaching 2022 level. | |
| Diabetes Operating Unit | Diabetes Operating Unit segment profit margin ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
Segment Profit Margin: Cardiovascular Portfolio
Medtronic PLC; Cardiovascular Portfolio; segment profit margin calculation
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Segment operating profit | 4,474) | 4,435) | 4,512) | 3,850) | 3,719) | 4,532) |
| Net sales | 11,831) | 11,573) | 11,423) | 10,772) | 10,468) | 11,505) |
| Segment Profitability Ratio | ||||||
| Segment profit margin1 | 37.82% | 38.32% | 39.50% | 35.74% | 35.53% | 39.39% |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 2024 Calculation
Segment profit margin = 100 × Segment operating profit ÷ Net sales
= 100 × 4,474 ÷ 11,831 = 37.82%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment profit margin | Cardiovascular Portfolio | Cardiovascular Portfolio segment profit margin ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
Segment Profit Margin: Neuroscience Portfolio
Medtronic PLC; Neuroscience Portfolio; segment profit margin calculation
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Segment operating profit | 3,940) | 3,617) | 3,765) | 3,162) | 2,915) | 3,319) |
| Net sales | 9,406) | 8,959) | 8,784) | 8,195) | 7,725) | 8,183) |
| Segment Profitability Ratio | ||||||
| Segment profit margin1 | 41.89% | 40.37% | 42.86% | 38.58% | 37.73% | 40.56% |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 2024 Calculation
Segment profit margin = 100 × Segment operating profit ÷ Net sales
= 100 × 3,940 ÷ 9,406 = 41.89%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment profit margin | Neuroscience Portfolio | Neuroscience Portfolio segment profit margin ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 not reaching 2022 level. |
Segment Profit Margin: Medical Surgical Portfolio
Medtronic PLC; Medical Surgical Portfolio; segment profit margin calculation
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Segment operating profit | 3,170) | 2,856) | 3,572) | 3,021) | 3,044) | 3,262) |
| Net sales | 8,417) | 8,433) | 9,141) | 8,737) | 8,352) | 8,478) |
| Segment Profitability Ratio | ||||||
| Segment profit margin1 | 37.66% | 33.87% | 39.08% | 34.58% | 36.45% | 38.48% |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 2024 Calculation
Segment profit margin = 100 × Segment operating profit ÷ Net sales
= 100 × 3,170 ÷ 8,417 = 37.66%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment profit margin | Medical Surgical Portfolio | Medical Surgical Portfolio segment profit margin ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 not reaching 2022 level. |
Segment Profit Margin: Diabetes Operating Unit
Medtronic PLC; Diabetes Operating Unit; segment profit margin calculation
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Segment operating profit | 394) | 378) | 583) | 598) | 546) | 739) |
| Net sales | 2,488) | 2,262) | 2,338) | 2,413) | 2,368) | 2,391) |
| Segment Profitability Ratio | ||||||
| Segment profit margin1 | 15.84% | 16.71% | 24.94% | 24.78% | 23.06% | 30.91% |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 2024 Calculation
Segment profit margin = 100 × Segment operating profit ÷ Net sales
= 100 × 394 ÷ 2,488 = 15.84%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment profit margin | Diabetes Operating Unit | Diabetes Operating Unit segment profit margin ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
Segment Return on Assets (Segment ROA)
Medtronic PLC, ROA by reportable segment
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Cardiovascular Portfolio | 27.74% | 27.63% | 31.14% | 25.62% | 25.05% | 29.33% |
| Neuroscience Portfolio | 21.57% | 19.72% | 22.26% | 18.44% | 17.30% | 19.73% |
| Medical Surgical Portfolio | 9.44% | 7.88% | 9.67% | 7.68% | 7.67% | 7.92% |
| Diabetes Operating Unit | 9.86% | 9.62% | 15.35% | 16.29% | 17.25% | 23.88% |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment ROA | Cardiovascular Portfolio | Cardiovascular Portfolio segment ROA deteriorated from 2022 to 2023 but then slightly improved from 2023 to 2024. |
| Neuroscience Portfolio | Neuroscience Portfolio segment ROA deteriorated from 2022 to 2023 but then improved from 2023 to 2024 not reaching 2022 level. | |
| Medical Surgical Portfolio | Medical Surgical Portfolio segment ROA deteriorated from 2022 to 2023 but then improved from 2023 to 2024 not reaching 2022 level. | |
| Diabetes Operating Unit | Diabetes Operating Unit segment ROA deteriorated from 2022 to 2023 but then slightly improved from 2023 to 2024. |
Segment ROA: Cardiovascular Portfolio
Medtronic PLC; Cardiovascular Portfolio; segment ROA calculation
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Segment operating profit | 4,474) | 4,435) | 4,512) | 3,850) | 3,719) | 4,532) |
| Total assets | 16,128) | 16,051) | 14,490) | 15,027) | 14,844) | 15,453) |
| Segment Profitability Ratio | ||||||
| Segment ROA1 | 27.74% | 27.63% | 31.14% | 25.62% | 25.05% | 29.33% |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 2024 Calculation
Segment ROA = 100 × Segment operating profit ÷ Total assets
= 100 × 4,474 ÷ 16,128 = 27.74%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment ROA | Cardiovascular Portfolio | Cardiovascular Portfolio segment ROA deteriorated from 2022 to 2023 but then slightly improved from 2023 to 2024. |
Segment ROA: Neuroscience Portfolio
Medtronic PLC; Neuroscience Portfolio; segment ROA calculation
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Segment operating profit | 3,940) | 3,617) | 3,765) | 3,162) | 2,915) | 3,319) |
| Total assets | 18,270) | 18,346) | 16,917) | 17,151) | 16,850) | 16,825) |
| Segment Profitability Ratio | ||||||
| Segment ROA1 | 21.57% | 19.72% | 22.26% | 18.44% | 17.30% | 19.73% |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 2024 Calculation
Segment ROA = 100 × Segment operating profit ÷ Total assets
= 100 × 3,940 ÷ 18,270 = 21.57%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment ROA | Neuroscience Portfolio | Neuroscience Portfolio segment ROA deteriorated from 2022 to 2023 but then improved from 2023 to 2024 not reaching 2022 level. |
Segment ROA: Medical Surgical Portfolio
Medtronic PLC; Medical Surgical Portfolio; segment ROA calculation
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Segment operating profit | 3,170) | 2,856) | 3,572) | 3,021) | 3,044) | 3,262) |
| Total assets | 33,586) | 36,248) | 36,940) | 39,319) | 39,666) | 41,186) |
| Segment Profitability Ratio | ||||||
| Segment ROA1 | 9.44% | 7.88% | 9.67% | 7.68% | 7.67% | 7.92% |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 2024 Calculation
Segment ROA = 100 × Segment operating profit ÷ Total assets
= 100 × 3,170 ÷ 33,586 = 9.44%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment ROA | Medical Surgical Portfolio | Medical Surgical Portfolio segment ROA deteriorated from 2022 to 2023 but then improved from 2023 to 2024 not reaching 2022 level. |
Segment ROA: Diabetes Operating Unit
Medtronic PLC; Diabetes Operating Unit; segment ROA calculation
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Segment operating profit | 394) | 378) | 583) | 598) | 546) | 739) |
| Total assets | 3,996) | 3,930) | 3,797) | 3,671) | 3,165) | 3,095) |
| Segment Profitability Ratio | ||||||
| Segment ROA1 | 9.86% | 9.62% | 15.35% | 16.29% | 17.25% | 23.88% |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 2024 Calculation
Segment ROA = 100 × Segment operating profit ÷ Total assets
= 100 × 394 ÷ 3,996 = 9.86%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment ROA | Diabetes Operating Unit | Diabetes Operating Unit segment ROA deteriorated from 2022 to 2023 but then slightly improved from 2023 to 2024. |
Segment Asset Turnover
Medtronic PLC, asset turnover by reportable segment
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Cardiovascular Portfolio | 0.73 | 0.72 | 0.79 | 0.72 | 0.71 | 0.74 |
| Neuroscience Portfolio | 0.51 | 0.49 | 0.52 | 0.48 | 0.46 | 0.49 |
| Medical Surgical Portfolio | 0.25 | 0.23 | 0.25 | 0.22 | 0.21 | 0.21 |
| Diabetes Operating Unit | 0.62 | 0.58 | 0.62 | 0.66 | 0.75 | 0.77 |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
| Segment activity ratio | Reportable segment | The company |
|---|---|---|
| Segment asset turnover | Cardiovascular Portfolio | Cardiovascular Portfolio segment asset turnover ratio deteriorated from 2022 to 2023 but then slightly improved from 2023 to 2024. |
| Neuroscience Portfolio | Neuroscience Portfolio segment asset turnover ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 not reaching 2022 level. | |
| Medical Surgical Portfolio | Medical Surgical Portfolio segment asset turnover ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level. | |
| Diabetes Operating Unit | Diabetes Operating Unit segment asset turnover ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level. |
Segment Asset Turnover: Cardiovascular Portfolio
Medtronic PLC; Cardiovascular Portfolio; segment asset turnover calculation
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net sales | 11,831) | 11,573) | 11,423) | 10,772) | 10,468) | 11,505) |
| Total assets | 16,128) | 16,051) | 14,490) | 15,027) | 14,844) | 15,453) |
| Segment Activity Ratio | ||||||
| Segment asset turnover1 | 0.73 | 0.72 | 0.79 | 0.72 | 0.71 | 0.74 |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 2024 Calculation
Segment asset turnover = Net sales ÷ Total assets
= 11,831 ÷ 16,128 = 0.73
| Segment activity ratio | Reportable segment | The company |
|---|---|---|
| Segment asset turnover | Cardiovascular Portfolio | Cardiovascular Portfolio segment asset turnover ratio deteriorated from 2022 to 2023 but then slightly improved from 2023 to 2024. |
Segment Asset Turnover: Neuroscience Portfolio
Medtronic PLC; Neuroscience Portfolio; segment asset turnover calculation
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net sales | 9,406) | 8,959) | 8,784) | 8,195) | 7,725) | 8,183) |
| Total assets | 18,270) | 18,346) | 16,917) | 17,151) | 16,850) | 16,825) |
| Segment Activity Ratio | ||||||
| Segment asset turnover1 | 0.51 | 0.49 | 0.52 | 0.48 | 0.46 | 0.49 |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 2024 Calculation
Segment asset turnover = Net sales ÷ Total assets
= 9,406 ÷ 18,270 = 0.51
| Segment activity ratio | Reportable segment | The company |
|---|---|---|
| Segment asset turnover | Neuroscience Portfolio | Neuroscience Portfolio segment asset turnover ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 not reaching 2022 level. |
Segment Asset Turnover: Medical Surgical Portfolio
Medtronic PLC; Medical Surgical Portfolio; segment asset turnover calculation
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net sales | 8,417) | 8,433) | 9,141) | 8,737) | 8,352) | 8,478) |
| Total assets | 33,586) | 36,248) | 36,940) | 39,319) | 39,666) | 41,186) |
| Segment Activity Ratio | ||||||
| Segment asset turnover1 | 0.25 | 0.23 | 0.25 | 0.22 | 0.21 | 0.21 |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 2024 Calculation
Segment asset turnover = Net sales ÷ Total assets
= 8,417 ÷ 33,586 = 0.25
| Segment activity ratio | Reportable segment | The company |
|---|---|---|
| Segment asset turnover | Medical Surgical Portfolio | Medical Surgical Portfolio segment asset turnover ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level. |
Segment Asset Turnover: Diabetes Operating Unit
Medtronic PLC; Diabetes Operating Unit; segment asset turnover calculation
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net sales | 2,488) | 2,262) | 2,338) | 2,413) | 2,368) | 2,391) |
| Total assets | 3,996) | 3,930) | 3,797) | 3,671) | 3,165) | 3,095) |
| Segment Activity Ratio | ||||||
| Segment asset turnover1 | 0.62 | 0.58 | 0.62 | 0.66 | 0.75 | 0.77 |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
1 2024 Calculation
Segment asset turnover = Net sales ÷ Total assets
= 2,488 ÷ 3,996 = 0.62
| Segment activity ratio | Reportable segment | The company |
|---|---|---|
| Segment asset turnover | Diabetes Operating Unit | Diabetes Operating Unit segment asset turnover ratio deteriorated from 2022 to 2023 but then improved from 2023 to 2024 exceeding 2022 level. |
Net sales
Medtronic PLC, net sales by reportable segment
US$ in millions
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Cardiovascular Portfolio | 11,831) | 11,573) | 11,423) | 10,772) | 10,468) | 11,505) |
| Neuroscience Portfolio | 9,406) | 8,959) | 8,784) | 8,195) | 7,725) | 8,183) |
| Medical Surgical Portfolio | 8,417) | 8,433) | 9,141) | 8,737) | 8,352) | 8,478) |
| Diabetes Operating Unit | 2,488) | 2,262) | 2,338) | 2,413) | 2,368) | 2,391) |
| Segments | 32,142) | 31,227) | 31,686) | 30,117) | 28,913) | 30,557) |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
Segment operating profit
Medtronic PLC, segment operating profit by reportable segment
US$ in millions
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Cardiovascular Portfolio | 4,474) | 4,435) | 4,512) | 3,850) | 3,719) | 4,532) |
| Neuroscience Portfolio | 3,940) | 3,617) | 3,765) | 3,162) | 2,915) | 3,319) |
| Medical Surgical Portfolio | 3,170) | 2,856) | 3,572) | 3,021) | 3,044) | 3,262) |
| Diabetes Operating Unit | 394) | 378) | 583) | 598) | 546) | 739) |
| Segments | 11,978) | 11,286) | 12,432) | 10,631) | 10,224) | 11,852) |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).
Total assets
Medtronic PLC, total assets by reportable segment
US$ in millions
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | Apr 26, 2019 | |
|---|---|---|---|---|---|---|
| Cardiovascular Portfolio | 16,128) | 16,051) | 14,490) | 15,027) | 14,844) | 15,453) |
| Neuroscience Portfolio | 18,270) | 18,346) | 16,917) | 17,151) | 16,850) | 16,825) |
| Medical Surgical Portfolio | 33,586) | 36,248) | 36,940) | 39,319) | 39,666) | 41,186) |
| Diabetes Operating Unit | 3,996) | 3,930) | 3,797) | 3,671) | 3,165) | 3,095) |
| Segments | 71,980) | 74,575) | 72,144) | 75,168) | 74,525) | 76,559) |
Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).